EJENDOMSMÆGLERFIRMAET TOXEN-WORM ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.1% 2.1% 2.1% 2.1% 2.1%  
Bankruptcy risk  5.1% 2.5% 2.2% 3.3% 2.7%  
Credit score (0-100)  45 62 64 54 60  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  917 1,014 1,127 1,095 1,019  
EBITDA  190 305 254 12.5 121  
EBIT  190 305 254 12.5 121  
Pre-tax profit (PTP)  182.6 300.2 252.7 14.9 118.3  
Net earnings  141.9 234.1 196.9 11.5 92.1  
Pre-tax profit without non-rec. items  183 300 253 14.9 118  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  653 637 584 345 437  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,067 1,024 951 737 834  

Net Debt  -1,031 -878 -751 -339 -574  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  917 1,014 1,127 1,095 1,019  
Gross profit growth  -2.3% 10.5% 11.1% -2.8% -6.9%  
Employees  1 1 2 2 2  
Employee growth %  0.0% 0.0% 100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,067 1,024 951 737 834  
Balance sheet change%  -20.4% -4.1% -7.1% -22.5% 13.2%  
Added value  190.2 305.1 254.5 12.5 120.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.7% 30.1% 22.6% 1.1% 11.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  16.1% 29.6% 26.7% 2.4% 15.5%  
ROI %  27.1% 47.4% 42.7% 4.2% 30.2%  
ROE %  20.1% 36.3% 32.3% 2.5% 23.5%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  61.1% 62.2% 61.4% 51.7% 57.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -542.1% -287.7% -295.1% -2,712.7% -476.0%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.6 2.7 2.6 2.4 2.6  
Current Ratio  2.6 2.7 2.6 1.9 2.2  
Cash and cash equivalent  1,031.2 877.7 750.9 339.4 573.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  660.6 645.2 591.5 356.3 448.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  190 305 127 6 60  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  190 305 127 6 60  
EBIT / employee  190 305 127 6 60  
Net earnings / employee  142 234 98 6 46